This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Shandong Luye Pharmaceutical Co., Ltd.. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2021
Title: **Inventor Profile: Xin Shao**
Introduction
Xin Shao is an innovative inventor based in Shandong, China, recognized for his contributions to the pharmaceutical field. With a focus on breakthroughs in drug formulations, he holds two patents that demonstrate his expertise and creativity in addressing medical challenges.
Latest Patents
Xin Shao's latest patents include the significant development of "Rotigotine behenate." This invention outlines methods for preparing the compound and its applications for treating diseases associated with dopamine receptors. The unique structure of rotigotine behenate enables it to reduce fluctuations in blood drug concentrations, improving the drug's bioavailability in vivo. Furthermore, it achieves a smooth and extended release of rotigotine, offering a promising solution for patients requiring consistent medication effects.
Career Highlights
Xin Shao works at Shandong Luye Pharmaceutical Co., Ltd., a notable organization in the pharmaceutical sector. His role in this company has allowed him to lead innovative projects that blend scientific research with practical applications in medication. His patents reflect a keen understanding of both the scientific principles and the market needs.
Collaborations
Throughout his career, Xin has collaborated with talented individuals, including Mina Yang and Yongtao Jiang. These partnerships highlight his commitment to teamwork and the collective pursuit of groundbreaking innovations in the pharmaceutical industry.
Conclusion
With his expertise and dedication, Xin Shao stands out as a prominent inventor in the realm of pharmaceutical innovations. His work not only contributes to the scientific community but also has the potential to improve the quality of life for patients through advanced therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile